D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AQST holding history
Aquestive Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AQST overviewAll 13F holders of AQSTFull Q2 2026 holdings
- Shares (Q2 2026)
- 37,640
- Value
- $156.6K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 37,640 | $156.6K | <0.1% | +19,491+107.4% | Added | Holders |
| Q1 2026 | 18,149 | $75.3K | <0.1% | −923,048−98.1% | Reduced | Holders |
| Q4 2025 | 941,197 | $6.08M | <0.1% | +915,697+3,591.0% | Added | Holders |
| Q3 2025 | 25,500 | $142.5K | <0.1% | −39,176−60.6% | Reduced | Holders |
| Q2 2025 | 64,676 | $214.1K | <0.1% | −114,359−63.9% | Reduced | Holders |
| Q1 2025 | 179,035 | $519.2K | <0.1% | +52,571+41.6% | Added | Holders |
| Q4 2024 | 126,464 | $450.2K | <0.1% | +95,418+307.3% | Added | Holders |
| Q3 2024 | 31,046 | $154.6K | <0.1% | +20,858+204.7% | Added | Holders |
| Q2 2024 | 10,188 | $26.5K | <0.1% | −85,025−89.3% | Reduced | Holders |
| Q1 2024 | 95,213 | $405.6K | <0.1% | +95,213 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −164,607−100.0% | Sold out | Holders |
| Q2 2022 | 164,607 | $106.0K | <0.1% | +55,769+51.2% | Added | Holders |
| Q1 2022 | 108,838 | $284.0K | <0.1% | +21,052+24.0% | Added | Holders |
| Q4 2021 | 87,786 | $341.0K | <0.1% | +87,786 | New | Holders |